(2023)
Intercellular cross-talk through lineage-specific gap junction of cancer-associated fibroblasts related to stromal fibrosis and prognosis.
SCIENTIFIC REPORTS.
13,
1
(2023)
Revised Nodal Staging Integrating Tumor Deposit Counts With Positive Lymph Nodes in Patients With Stage III Colon Cancer.
ANNALS OF SURGERY.
277,
4
(2023)
Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
INFLAMMATORY BOWEL DISEASES.
29,
2
(2022)
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specimens; prediction of lymph node metastasis in T1 colorectal cancer.
JOURNAL OF GASTROENTEROLOGY.
57,
9
(2022)
Integrated Analysis of Single-Cell and Spatial Transcriptomics in Keloids: Highlights on Fibrovascular Interactions in Keloid.
JOURNAL OF INVESTIGATIVE DERMATOLOGY.
142,
8
(2022)
NTRK Fusions in 1113 Solid Tumors in a Single Institution.
DIAGNOSTICS.
12,
6
(2022)
PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression.
NATURE COMMUNICATIONS.
13,
1
(2022)
Expression of SLC22A18 regulates oxaliplatin resistance by the ERK in colorectal cancer.
AMERICAN JOURNAL OF CANCER RESEARCH.
12,
3
(2021)
Tumor Budding as a Prognostic Marker in Rectal Cancer Patients on Propensity Score Analysis.
ANNALS OF SURGICAL ONCOLOGY.
28,
13
(2021)
Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY.
147,
12
(2021)
Integrated single-cell RNA sequencing analyses suggest developmental paths of cancer-associated fibroblasts with gene expression dynamics.
CLINICAL AND TRANSLATIONAL MEDICINE.
11,
7
(2021)
Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY.
147,
2
(2020)
SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
EXPERIMENTAL AND MOLECULAR PATHOLOGY.
117,
(2020)
Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer.
NATURE GENETICS.
52,
6
(2020)
New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts.
SCIENTIFIC REPORTS.
10,
1
(2020)
Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.
CANCER RESEARCH AND TREATMENT.
52,
2
(2020)
Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase.
CANCERS.
12,
1
(2020)
Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting Colorectal Cancer Cells into Differentiated Normal-Like Cells.
MOLECULAR CANCER RESEARCH.
18,
1
(2019)
Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy.
SURGERY.
165,
3
(2019)
Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.
JOURNAL OF EXPERIMENTAL CLINICAL CANCER RESEARCH.
38,
1
